USPTO Examiner ELLABIB MAAP AHMED - Art Unit 3785

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19178216METHOD AND APPARATUS FOR SWITCHING OXYGEN SUPPLY MODE, DEVICE AND STORAGE MEDIUMApril 2025November 2025Allow710NoNo
18987753MICROFLUIDIC PLATFORM FOR SHEAR-LESS AEROSOLIZATION OF LIPID NANOPARTICLES FOR MESSENGER RNA INHALATIONDecember 2024March 2026Allow1521YesNo
18987781MICROFLUIDIC PLATFORM FOR SHEAR-LESS AEROSOLIZATION OF LIPID NANOPARTICLES FOR MESSENGER RNA INHALATIONDecember 2024March 2026Allow1521YesNo
18786198Bidirectional Spirometer T-PieceJuly 2024May 2025Allow1010NoNo
18583084CPAP SYSTEMFebruary 2024April 2025Allow1410YesNo
18384596HUMIDIFICATION INTERFACE ARRANGEMENTSOctober 2023January 2025Allow1520NoNo
18377084MIXING CHANNEL FOR AN INHALATION DEVICE AND INHALATION DEVICEOctober 2023January 2025Allow1620NoNo
18478857VERSATILE AND MULTI-PURPOSE BREATHING MASKSeptember 2023April 2024Allow700YesNo
18169096SYMMETRICAL FLOW RESPIRATORFebruary 2023March 2026Abandon3731YesNo
17731256Substance Delivery Device and MethodsApril 2022October 2025Allow4210YesNo
17712861ACCURATE PRESSURE MEASUREMENT WITH NON-INVASIVE VENTILATION NASAL PILLOWSApril 2022December 2025Allow4411YesNo
17642182SYSTEM FOR DELIVERING BREATHING GAS TO PASSENGERSMarch 2022June 2025Allow3910NoNo
17753634Noise Reduction Box and Ventilation Therapeutic DeviceMarch 2022January 2026Abandon4621NoNo
17677436RESPIRATORY ASSEMBLY WITH CONDUIT ADAPTER AND METHODS OF USEFebruary 2022July 2025Allow4110NoNo
17650016RESPIRATORFebruary 2022April 2025Allow3820NoNo
17581530GAS DISTRIBUTOR FOR REBREATHER SUPPORTING CLOSED AND OPEN CIRCUIT MODESJanuary 2022December 2025Allow4720NoNo
17628778MASKJanuary 2022June 2025Abandon4110NoNo
17572356MASK APPARATUSJanuary 2022January 2026Abandon4820NoNo
17646469PRESSURE RELEASE AND MASSAGE TOOLDecember 2021August 2024Allow3231YesNo
17536847SELECTIVELY PIVOTABLE FACE SHIELD DEVICE, SYSTEM, AND METHOD FOR USE WITH USER HEADGEAR AND FOR PHYSICALLY BLOCKING NOXIOUS AIRBORNE SUBSTANCESNovember 2021October 2025Allow4602NoNo
17608532IMPROVEMENTS RELATING TO INHALERSNovember 2021December 2025Abandon4901NoNo
17492822METHOD AND SYSTEM FOR AUTOMATING OXYGEN MONITORING AND DOSING IN REAL TIME FOR PATIENT ON OXYGEN THERAPYOctober 2021December 2025Abandon5011NoNo
17436392INTUBATION BOUGIESeptember 2021September 2025Allow4820NoNo
17465517SYSTEMS AND METHODS FOR ACTIVE HUMIDIFICATION IN VENTILATORY SUPPORTSeptember 2021May 2025Allow4520YesNo
17343952ADJUSTABLE INFLATABLE NECK SUPPORT DEVICE AND METHOD FOR MANUFACTURING THE SAMEJune 2021August 2025Abandon5020NoNo
17332314Respiratory Protective DeviceMay 2021January 2025Abandon4310NoNo
17323202SELF-RIGHTING UNDERWATER ESCAPE AND SURFACE SURVIVAL SUIT SYSTEMMay 2021October 2025Allow5320YesNo
17293544APPARATUS AND METHODS FOR MULTI-CHAMBER, MULTI-ATOMIZER VAPORIZATION DEVICESMay 2021February 2025Abandon4610NoNo
17306997PORTABLE OXYGEN GENERATOR SYSTEMMay 2021November 2024Allow4310NoNo
17306892System and Method For Ventilating a PersonMay 2021November 2023Abandon3010NoNo
17246712LIQUID ADMINISTERING DEVICEMay 2021December 2023Allow3210YesNo
17242873PROCESS AND DEVICE FOR DETECTION OF A LEAK IN A VENTILATION CIRCUITApril 2021December 2025Allow5540YesYes
17241433Active Lung Assist DeviceApril 2021September 2024Allow4001NoNo
17222339MASK WITH FILTERApril 2021October 2023Abandon3110NoNo
17210029APPARATUS, SYSTEMS AND METHODS FOR DELIVERING CONDITIONED AIR TO A PATIENT LUNG INTUBATION TUBEMarch 2021September 2025Abandon5340NoNo
17204422MEDICAL VENTILATOR WITH AIR INLETS THAT ARE PROTECTED BY FILTERS ARRANGED IN A DETACHABLE COMMON FILTRATION CARTRIDGEMarch 2021October 2023Abandon3110NoNo
17197135RESPIRATORY MASK ASSEMBLY FOR USE WITH CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) EQUIPMENTMarch 2021June 2025Allow5121NoNo
17196624Ventilation System and MethodMarch 2021July 2023Allow2810NoNo
17191066SYSTEMS AND METHODS FOR PROVIDING CONTROLLED SUPPLEMENTAL OXYGEN VIA ANY VENTILATORMarch 2021December 2023Allow3421YesNo
17270643METHODS AND APPARATUS FOR CONTROLLING RESPIRATORY THERAPY WITH SUPPLEMENTARY OXYGENFebruary 2021September 2024Abandon4301NoNo
17167409METHOD FOR CONTROLLING FLUID JET PLUME CHARACTERISTICSFebruary 2021June 2024Abandon4140YesNo
17147448INFLATABLE NECK TRACTION DEVICEJanuary 2021May 2024Allow4030YesNo
17135732BREATHING DEVICES AND RELATED SYSTEMS AND METHODSDecember 2020March 2025Abandon5030YesNo
17111209LIQUID NEBULIZATION SYSTEMS AND METHODSDecember 2020June 2024Abandon4320NoNo
15734541INTERFACE ASSEMBLIES FOR RESPIRATORY THERAPYDecember 2020October 2024Allow4620NoNo
17059850CAPTURE OF XENON FROM ANAESTHETIC GAS AND RE-ADMINISTRATION THEREOF TO THE PATIENTNovember 2020March 2024Abandon4010NoNo
17250047LUNG RECRUITMENT IN MECHANICAL VENTILATIONNovember 2020November 2024Allow4830NoNo
17054922MICRO NOZZLE ASSEMBLYNovember 2020June 2024Allow4410NoNo
17048263LIQUID VENTILATOR AND METHOD TO INDUCE TIDAL LIQUID VENTILATION AND/OR HYPORTHERMIAOctober 2020May 2024Allow4320NoNo
16875906Single-Use Nasal Delivery DeviceMay 2020October 2023Allow4110YesNo
16852197SYSTEMS AND METHODS FOR DETECTING RESPIRATORY MECHANICSApril 2020February 2024Allow4600YesNo
16850703CPAP SYSTEMApril 2020November 2023Allow4300YesNo
16850801PRESSURE RELEASE AND MASSAGE TOOLApril 2020October 2024Allow5441YesNo
16850047HUMIDIFICATION INTERFACE ARRANGEMENTSApril 2020August 2023Allow4020YesNo
16756816FINGER EXERCISERApril 2020June 2023Allow3810NoNo
16756132THREE-WAY VALVE AND PATIENT CIRCUIT ADAPTOR FOR A MEDICAL VENTILATORApril 2020August 2024Allow5211YesNo
16755028DEVICE FOR VENTILATING A PATIENTApril 2020July 2024Allow5230NoNo
16754585DRUG DELIVERY SYSTEMS AND RELATED METHODSApril 2020July 2023Allow4000YesNo
16753845VENTILATOR WITH AUTOMATIC DETECTION OF A FAULT IN A FLOW SENSOR, TAKING INTO ACCOUNT SPONTANEOUS BREATHINGApril 2020July 2024Allow5220YesYes
16830402MECHANICAL CARDIOPULMONARY RESUSCITATION DEVICEMarch 2020August 2023Abandon4001NoNo
16649012NEBULIZER ORIENTATION APPARATUSMarch 2020August 2025Allow6031NoNo
16648619Endo-Tracheal Catheter for Use in an Anesthetic ProcedureMarch 2020December 2023Allow4520YesNo
16822408MULTI-LAYERS CUSHION ASSEMBLY FOR A PATIENT INTERFACEMarch 2020March 2023Allow3610NoNo
16815411RESPIRATORY MONITOR IN A NONINVASIVE VENTILATORMarch 2020January 2025Abandon5850YesNo
16644005VERSATILE AND MULTI-PURPOSE BREATHING MASKMarch 2020September 2023Allow4311YesNo
16807699RESPIRATORY MASKMarch 2020June 2023Abandon3910NoNo
16797621COUNTERTOP WATER FLOSSERFebruary 2020October 2023Allow4421YesNo
16793393NASAL CANNULA FOR A PORTABLE OXYGEN CONCENTRATORFebruary 2020March 2024Abandon4920NoNo
16773574ORAL CAVITY WASHING DEVICEJanuary 2020October 2023Abandon4420NoNo
16632339Single-Dose Powder-Medication InhalerJanuary 2020September 2023Abandon4420NoNo
16487019SYSTEM FOR DETECTION OF LEAKAGE OR ABNORMAL RESISTANCE IN A VENTILATION SYSTEMAugust 2019December 2024Allow6050YesNo
16342839Bioelectrically Controlled Ventilation ModeApril 2019February 2026Abandon6020NoYes

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ELLABIB, MAAP AHMED.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
0
(0.0%)
Examiner Reversed
1
(100.0%)
Reversal Percentile
99.6%
Higher than average

What This Means

With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
3
Allowed After Appeal Filing
2
(66.7%)
Not Allowed After Appeal Filing
1
(33.3%)
Filing Benefit Percentile
93.0%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 66.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner ELLABIB, MAAP AHMED - Prosecution Strategy Guide

Executive Summary

Examiner ELLABIB, MAAP AHMED works in Art Unit 3785 and has examined 54 patent applications in our dataset. With an allowance rate of 61.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 44 months.

Allowance Patterns

Examiner ELLABIB, MAAP AHMED's allowance rate of 61.1% places them in the 21% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by ELLABIB, MAAP AHMED receive 1.76 office actions before reaching final disposition. This places the examiner in the 38% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by ELLABIB, MAAP AHMED is 44 months. This places the examiner in the 15% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +42.6% benefit to allowance rate for applications examined by ELLABIB, MAAP AHMED. This interview benefit is in the 89% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 36.1% of applications are subsequently allowed. This success rate is in the 82% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 40.0% of cases where such amendments are filed. This entry rate is in the 61% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 23% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 52% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 7% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.